| ²é¿´: 748 | »Ø¸´: 6 | |||
[½»Á÷]
ÎÄÏ×·ÖÏí | ÃâÒßµ÷¿ØÁªºÏÉñ¾µ÷¿Ø£¬IFÓÉ11.4Ìá¸ßΪ25.5
|
|||
|
ÃâÒßµ÷¿ØÊÇÖ¸»úÌå¶ÔÍâ½ç´Ì¼¤×ö³öµÄÃâÒß·´Ó¦¹ý³ÌÖУ¬Í¨¹ý¸÷ÖÖµ÷¿Ø»úÖÆÀ´±£³ÖÃâÒ߯½ºâ״̬£¬ÒÔ¼°»Ö¸´Õý³£ÃâÒßÓ¦´ðµÄÄÜÁ¦¡£ ½üÄêÀ´£¬ÃâÒßµ÷¿ØÏà¹ØµÄÑо¿²ã³ö²»Ç2023ÄêÖбêÊý¸ß´ï985¸ö£¬¿É¼û´ó¼Ò¶ÔÓÚÕâÒ»Ñо¿·½ÏòµÄÈÈÖÔ¡£½ñÌìСÖúÊÖ¸ø´ó¼ÒÕûÀíÁ˼¸Æª½üÄê·¢±íµÄ¸ß·ÖÎÄÕ£¬Óë´ó¼Ò¹²Í¬Ñ§Ï°Ò»ÏÂÃâÒßµ÷¿Ø·½ÏòÓÐÄÄЩеÄÑо¿Ë¼Â·¡£ 1¡¢Cell£¨IF=64.5£©£¬C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection ϵͳÐÔÄîÖé¾ú¸ÐȾÊÇÒ»ÖÖ³£¼ûµÄ¡¢¸ßËÀÍöÂʵÄÒ½ÔºÕæ¾ú¸ÐȾ¡£³öºõÒâÁϵÄÊÇ£¬ËüÒѳÉΪ¿¹²¹ÌåC5°ÐÏòµ¥¿Ë¡¿¹ÌåÖÎÁƵIJ¢·¢Ö¢£¬±íÃ÷C5ÔÚ¿¹Õæ¾úÃâÒßÖоßÓÐÏà¹Ø×÷Óᣱ¾´ÎÑо¿È·¶¨ÁËÔÚÄîÖé¾úѪ֢»¼ÕßÖÐÓÕµ¼µÄ²¹Ìåϵͳ»ùÒòת¼ΪÊ×λµÄÉúÎï;¾¶£¬²¢Ô¤²âÆäÓëÄîÖé¾úѪ֢µÄÏà¹ØÐÔ¡£´Ó»úÖÆÉÏ¿´£¬C5a-C5aR1ͨ¹ý´Ì¼¤ÍÌÊÉϸ°ûЧӦ¹¦ÄÜÒÔ¼°ERKºÍAKTÒÀÀµµÄ¸ÐȾ×éÖ¯´æ»î£¬´Ù½øÐ¡ÊóÈ«ÉíÐÔÄîÖé¾ú²¡Ä£ÐÍÖеÄÕæ¾úÇå³ýºÍËÞÖ÷´æ»î¡£ÇóýC5ar1»ùÒòÖØ¹¹ÁËmTORÏÂÓεľÞÊÉϸ°û´úл£¬´Ù½øÁËËüÃǵĵòÍö£¬²¢Í¨¹ýÉöËðÉËÔö¼ÓÁËËÀÍöÂÊ¡£³ýÁ˸Îϸ°ûÀ´Ô´µÄ C5£¬ÓÉÍÌÊÉϸ°ûÄÚÔ´ÐÔ²úÉúµÄC5ÌṩÁË¿¹Õæ¾ú±£»¤µÄ¹Ø¼üµ×ÎѪÇåµÍC5aŨ¶È»ò¼õÉÙ°×ϸ°û C5±í´ïµÄC5¶à̬ÐÔÓ뻼ÕßÔ¤ºó²»Á¼Ïà¹Ø¡£×ÛÉÏËùÊö£¬¾Ö²¿ÍÌÊÉϸ°û²úÉúµÄC5²úÎïÊÚȨÁËÍÌÊÉϸ°ûµÄ¿¹Î¢ÉúÎ﹦ÄÜ£¬²¢ÔÚÈ«ÉíÕæ¾ú¸ÐȾ¹ý³ÌÖÐÌṩ¹ÌÓб£»¤¡£ 2¡¢Bioactive Materials£¨IF=18.9£©£¬A multifunctional neuromodulation platform utilizing Schwann cell-derived exosomes orchestrates bone microenvironment via immunomodulation, angiogenesis and osteogenesis ×î½üµÄÑо¿Ö¤Ã÷ÁËÔÚ¹ÇÔÙÉúÖÐÖØÏÖ¹Ç΢»·¾³ÖÐµÄ¶à·½ÃæÉúÎïѧÐèÇó¡£Éñ¾»¯¶ÔÓÚʵÏÖ¹Ç×éÖ¯¹¤³Ì£¨BTE£©ÖеĶàϵͳµ÷¿Ø¾ßÓо޴óDZÁ¦¡£È»¶ø£¬ËùÓÐÉæ¼°¹Ø¼ü¹ÇÐÞ¸´²½ÖèµÄÉñ¾²ßÂÔÉÐ䱨µÀ¡£ÔÚ±¾Ñо¿ÖУ¬Éñ¾×éÖ¯¹¤³ÌË®Äý½º·â×°µÄϸ°ûÀ´Ô´ÍâÃÚÌ壨SC Exo£©¡£ÕâÖÖ³ÖÐøÊÍ·ÅµÄ SC Exoϵͳͨ¹ý´Ù½øÌåÄÚµÄÉñ¾»¯¡¢ÃâÒßµ÷½Ú¡¢Ñª¹Ü»¯ºÍ³É¹Ç×÷ÓÃÏÔÖøÔöÇ¿Á˹ÇÔÙÉú¡£´ËÍ⣬ÌåÍâ½á¹û½øÒ»²½È·ÈÏÁ˸ÃϵͳÏÔÖøÓÕµ¼¾ÞÊÉϸ°ûµÄ M2¼«»¯¡¢HUVECsµÄ¹ÜÐγÉÒÔ¼° BMSCsµÄ³É¹Ç·Ö»¯¡£´ËÍ⣬ͨ¹ýÉϵ÷ TGF-¦Â1/SMAD2/3ÐźÅͨ·´Ù½øÁË BMSCsµÄ³É¹Ç¡£×ÛÉÏËùÊö£¬±¾Ñо¿ÖÐ×÷Õ߳ɹ¦¿ª·¢ÁËÒ»ÖÖеÄÎÞϸ°û¡¢Ò×ÓÚÖÆ±¸µÄ SC-ExoÉñ¾¹¤³Ì£¬Í¨¹ýе÷Õû¸ö¹ÇÓúºÏ΢»·¾³À´´Ù½ø¹ÇÔÙÉú£¬Õâ¿ÉÄÜΪ×éÖ¯¹¤³ÌºÍ¹ÇȱËðµÄÁÙ´²ÖÎÁÆÌṩһÖÖвßÂÔ¡£ 3¡¢Immunity£¨IF=32.4£©£¬Restraint of IFN-¦Ã expression through a distal silencer CNS-28 for tissue homeostasis IFN-¦ÃÊDz¸È鶯ÎïÓ¦¶Ô²¡¶¾»òϸ°ûÄÚϸ¾ú¸ÐȾµÄ¹Ø¼üϸ°ûÒò×Ó¡£ËäÈ»Ðí¶àÔöÇ¿×Ó±»ÃèÊöΪ´Ù½øIFN-¦Ã·´Ó¦£¬µ«»¹Ã»Óз¢ÏÖIfng»ùÒòµÄ³ÁĬÒò×Ó¡£Í¨¹ýÔÚIfng»ùÒòλµãÄÚµÄnaive CD4+Tϸ°ûÖмì²éH3K4me1×éµ°°×ÐÞÊΣ¬ÎÒÃǼø¶¨ÁËÒ»¸öÒÖÖÆÒò×Ó£¨CNS-28£©£¬¸ÃÒÖÖÆÒò×ÓÒÖÖÆIfng±í´ï¡£´Ó»úÖÆÉϽ²£¬CNS-28ͨ¹ýÒÔ GATA3ÒÀÀµT-betÒÀÀµµÄ·½Ê½¼õÉÙIfng»ùÒòλµãÄÚµÄÔöÇ¿×Ó-Æô¶¯×ÓÏ໥×÷ÓÃÀ´Î¬³ÖIfng³ÁĬ¡£ÔÚ¹¦ÄÜÉÏ£¬CNS-28ÔÚÏÈÌìÃâÒß·´Ó¦ºÍÊÊÓ¦ÐÔÃâÒß·´Ó¦ÆÚ¼äÒÖÖÆ NK ϸ°û¡¢CD4+ϸ°ûºÍ CD8+Tϸ°ûÖÐµÄ Ifngת¼¡£´ËÍ⣬ÓÉÓÚ IFN-¦Ã ±í´ïÉý¸ß£¬CNS-28 ȱ·¦µ¼ÖÂ2ÐÍ·´Ó¦±»ÒÖÖÆ£¬´Ó¶ø¸Ä±äÁËTh1ºÍTh2µÄģʽ¡£Òò´Ë£¬CNS-28»îÐÔͨ¹ýÓëIfng»ùÒòλµãÄ򵀮äËûµ÷¿ØË³Ê½Ôª¼þºÏ×÷£¬×î´óÏ޶ȵؼõÉÙ×ÔÉíÃâÒߣ¬´Ó¶øÈ·±£ÃâÒßϸ°û¾²Ö¹¡£ 4¡¢Nature Immunology£¨IF=30.5£©£¬Transcription factor EGR2 controls homing and pathogenicity of TH17 cells in the central nervous system TH17¼È±£»¤ÆÁÕÏ×éÖ¯ÓÖ´¥·¢×ÔÉíÃâÒß¡£ÕâЩ¶ÔÁ¢½ø³Ì±³ºóµÄ»úÖÆÉв»Çå³þ¡£±¾Ñо¿Öз¢ÏÖת¼Òò×ÓEGR2¿ØÖÆÖÐÊàÉñ¾ÏµÍ³£¨CNS£©ÖÐÖ²¡ÐÔTH17ϸ°ûµÄת¼³ÌÐò£¬µ«²»¿ØÖÆÆÁÕÏλµãµÄ±£»¤ÐÔTH17µÄת¼³ÌÐò¡£¶à·¢ÐÔÓ²»¯Ö¢»¼ÕߺÍ×ÔÉíÃâÒßÐÔÉñ¾Ñ×֢СÊóµÄËèÇÊ·´Ó¦ÐÔCD4+Tϸ°ûÖÐ EGR2ÏÔÖøÉý¸ß¡£EGR2ת¼³ÌÐò¾²Ä¬±àÖ¯ÔÚTH17ϸ°ûת¼µ÷¿ØÍøÂçÖУ¬²¢ÓëºËÐÄTH17ϸ°ûÌØÒìÐÔת¼Òò×ÓÖ®¼ä¾ßÓеĸ߶Ȼ¥ÁªÐÔ¡£´Ó»úÖÆÉϽ²£¬EGR2ͨ¹ýÉϵ÷Ó벡ÀýÏà¹Ø»ùÒòºÍËèÑùµ¥ºËϸ°ûÇ÷»¯Òò×Ó£¬ÔöÇ¿ TH17ϸ°û·Ö»¯ºÍËèÑùϸ°ûÏòCNSµÄ=¡£Egr2µÄTϸ°ûÌØÒìÐÔÇóýÔÚ²»Ëðº¦ËÞÖ÷¿ØÖƸÐȾÄÜÁ¦µÄÇé¿öϼõÇáÁËÉñ¾Ñ×Ö¢¡£×ÛÉÏËùÊö£¬EGR2ÔÚCNSµÄ²¡ÔÐÔTH17ϸ°ûÖе÷¿Ø×éÖ¯ÌØÒìºÍ¼²²¡ÌØÒ칦ÄÜ¡£ |
» ²ÂÄãϲ»¶
ºÓ±±Ò½¿Æ´óѧҩѧÏà¹Ø×¨Òµ½ÓÊܵ÷¼Á
ÒѾÓÐ20È˻ظ´
¡¾ÕÐÆ¸¡¿Ç廪´óѧҩѧԺǮ·æ½ÌÊÚ¿ÎÌâ×é³ÏƸ²©Ê¿ºó
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ193È˻ظ´
аæscifinder
ÒѾÓÐ1È˻ظ´
°²½ÝÂ×ÒºÏàÉ«Æ×ÖùÓë·½·¨¿ª·¢Ö¸ÄÏ
ÒѾÓÐ4È˻ظ´
2026ÉêÇ뿼ºË²©Ê¿×Ô¼ö-µ°°×ÖÊ×éѧ/AI/Ò©ÎïÉè¼Æ/AIDD/»¯Ñ§ÉúÎïѧ
ÒѾÓÐ1È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Öйú¿ÆÑ§Ôº´óѧÄÉÃ׿ÆÑ§Ó빤³ÌÑ§ÔºÌÆÖÇÓ£¨Ôº³¤£©-ÕÅÒøÍŶÓÕÐÆ¸ÆôÊÂ
+1/172
¿ÆÈðÈüÉúÎïÄÚÆ¤Ï¸°ûÅàÑø»ùÊÔÓÃ×°ÏÞʱ´ó·ÅËÍ£¬ÖúÁ¦ÄãµÄʵÑé¸ßЧ½ø½×£¡
+1/92
³É¶¼Àí¹¤´óѧȫ¹úÖØµãʵÑéÊÒ¹«¿ª³ÏƸÂÌÉ«ÓлúºÏ³É·½ÏòÁªÅàÉú¼°¿ÆÑÐÖúÀí
+1/78
ÉϺ£´óѧ¹ÜÀíѧԺÑô·¢¾ü½ÌÊÚ¿ÎÌâ×éȫְ²©Ê¿/²©Ê¿ºóÕÐÆ¸ÆôÊÂ
+1/77
ÃÀ¹úÃÜЪ¸ùÖÝÁ¢´óѧÁÖѧϵ¶Åº£Ë³¿ÎÌâ×éÕÐÊÕÈ«½±²©Ê¿Éú¼°ÁªºÏÅàÑø²©Ê¿Éú
+1/76
¹ãÖÝ
+1/65
À¥Ã÷Àí¹¤´óѧұÄÜÔºÀë×ÓÒºÌåÒ±½ð¿ÎÌâ×éÕÐÊÕ²©Ê¿
+1/60
¿¼ºËÖÆ²©Ê¿×Ô¼ö
+1/44
×ø±ê¼ÃÄÏ£¬É½¶«Å©¿ÆÔºÕÐ ÓлúºÏ³É or Ò©Îﻯѧ ÁªÅà˶ʿÑо¿Éú
+1/41
±±¾©ÁÖÒµ´óѧľÖÊËØ¸ßÖµ»¯ÀûÓô´ÐÂÍŶÓÕÐÊÕ2026ÄêÈëѧ²©Ê¿Éú
+1/31
Î÷ÄϽ»Í¨´óÑ§Ç°ÑØÔºÌ¼ÖкÍÓëÎïÖÊÑ»·ÀûÓÿÎÌâ×éÕÐÊÕ²©Ê¿Éú
+1/29
ÍõÖ¾²©½ÌÊÚ¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú(±¾ÕÐÊÕÐÅÏ¢³¤ÆÚÓÐЧ)
+2/20
ÉϺ£´óѧêÃÅô½ÌÊÚ¡¢¾üÊÂҽѧÑо¿Ôº²®Ïþ³¿Ñо¿Ô±/ÄßÃú¸±Ñо¿Ô± ¿ÎÌâ×éÕÐÆ¸²©Ê¿Éú
+2/16
Çൺ´óѧ ¶¡ÐÀ ¿ÎÌâ×é ÕÐÊÕ2026Çﻯѧ²©Ê¿1Ãû
+1/7
µç×ӿƼ¼´óѧ¼¤¹âÓë¹â×ÓÖÆÔìÍŶÓÕÐ˶ʿ²©Ê¿
+1/6
ÉϺ£´óѧÕŽø½ÌÊÚ¿ÎÌâ×é³ÏÕÐ2026ÄêÇï¼¾²©Ê¿Ñо¿Éú
+1/4
ÄÏÕÙöÎçù·½½âʯÓÐÏÞ¹«Ë¾ÑéÊÕ¿¢¹¤»·¾³±£»¤ÑéÊÕ¹«Ê¾
+1/3
ÀíÂÛ¼ÆË㣬¿É´úË㣬¿ÉºÏ×÷£¬»¶Ó½»Á÷
+1/2
ÉϺ£½»Í¨´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÅÖÇÌοÎÌâ×é³ÏƸ²©Ê¿ºó
+1/2
ÉϺ£Àí¹¤´óѧ ÉúÎïҽѧ¹¤³Ìרҵ ÕÐÊÕ2026ÄêÈ«ÈÕÖÆ²©Ê¿ÉúÒ»Ãû
+1/1
6Â¥2024-08-06 16:40:20
¼òµ¥»Ø¸´
tzynew2Â¥
2024-08-06 08:47
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
i ·¢×ÔСľ³æAndroid¿Í»§¶Ë
zusn3Â¥
2024-08-06 10:50
»Ø¸´
nono20094Â¥
2024-08-06 11:57
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
¡¤
tfang5Â¥
2024-08-06 16:00
»Ø¸´
ÉúÎïҽҩʵÑéÍâ°(½ð±Ò+1): лл²ÎÓë
¸ý³½ÐÁ³ó7Â¥
2024-08-06 17:13
»Ø¸´







»Ø¸´´ËÂ¥